icd10free.comPowered by Curo
E08.3392BillableSave

E08.3392 - Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy without macular edema, left eye

ICD-10-CM Chapter 4: Endocrine, nutritional and metabolic diseases · E08-E13 Diabetes mellitus (E08-E13) · Subcategory of E08.339 · FY2027

7th character 2: left eye

Coding Guidance

7th character 2: left eye.

Includes, Excludes and Coding Notes

Excludes 1 — Not Coded HereFrom E08

Mutually exclusive: these conditions are never reported together with this code.

  • drug or chemical induced diabetes mellitus (E09.-)
  • gestational diabetes (O24.4-)
  • neonatal diabetes mellitus (P70.2)
  • postpancreatectomy diabetes mellitus (E13.-)
  • postprocedural diabetes mellitus (E13.-)
  • secondary diabetes mellitus NEC (E13.-)
  • type 1 diabetes mellitus (E10.-)
  • type 2 diabetes mellitus (E11.-)
Use Additional CodeFrom E08

Add a secondary code to identify the associated condition or cause when it is documented.

  • code to identify control using:
  • injectable non-insulin antidiabetic drugs (Z79.85)
  • insulin (Z79.4)
  • oral antidiabetic drugs (Z79.84)
  • oral hypoglycemic drugs (Z79.84)
Code FirstFrom E08

Sequence the underlying condition before this code.

  • the underlying condition, such as:
  • congenital rubella (P35.0)
  • Cushing's syndrome (E24.-)
  • cystic fibrosis (E84.-)
  • malignant neoplasm (C00-C96)
  • malnutrition (E40-E46)
  • pancreatitis and other diseases of the pancreas (K85-K86.-)
Excludes 1 — Not Coded HereFrom Chapter E00-E89

Mutually exclusive: these conditions are never reported together with this code.

  • transitory endocrine and metabolic disorders specific to newborn (P70-P74)
NotesFrom Chapter E00-E89

Instructional notes from the ICD-10-CM tabular list.

  • All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.